Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000933358) titled 'A Study in Adult Volunteers to Understand the Safety and Effects of a New Drug, PTC612 - Part 1 (Single Ascending Dose) and Part 3 (Multiple Ascending Dose)' on July 29.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Primary Sponsor: PTC Therapeutics, Inc.
Condition:
inflammatory diseases
inflammatory diseases
Inflammatory and Immune System - Other inflammatory or immune system disorders
Intervention:
Part 1 Single Ascending Dose (SAD):
Part 1 of the study will evaluate single ascending oral doses of PTC612 in healthy p...